메뉴 건너뛰기




Volumn 38, Issue 4, 2001, Pages 376-385

Drug interference in clinical chemistry: Recommendation of drugs and their concentrations to be used in drug interference studies

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; ASCORBIC ACID; BILIRUBIN; CARBAMAZEPINE; CEFOXITIN; CREATINE KINASE MB; CREATININE; DOBESILATE CALCIUM; DOXYCYCLINE; DRUG METABOLITE; FRUCTOSAMINE; GENTAMICIN; IBUPROFEN; INTRALIPID; LEVODOPA; METHYLDOPA; METRONIDAZOLE; PARACETAMOL; PHENYLBUTAZONE; RHEUMATOID FACTOR; RIFAMPICIN; TETRACYCLINE; THEOPHYLLINE; TOBRAMYCIN; URIC ACID; VALPROIC ACID;

EID: 0034937475     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563011900696     Document Type: Article
Times cited : (45)

References (33)
  • 16
    • 0025826750 scopus 로고
    • In-vitro testing for interference by drugs in quantitative urine analysis: Results of an experts' discussion and initial experience gained with the new testing list
    • (1991) Lab Med , vol.15 , pp. 399-403
    • Appel, W.1    Hubbuch, A.2    Koller, P.U.3
  • 21
    • 0017198894 scopus 로고
    • Tabulation of therapeutic, toxic, and lethal concentrations of drugs and chemicals in blood
    • (1979) Clin Chem , vol.22 , pp. 832-836
    • Winek, C.L.1
  • 26
    • 0031907425 scopus 로고    scopus 로고
    • Guidelines for the interpretation of analytical toxicology results and unit of measurement conversion factor
    • (1998) Ann Clin Biochem , vol.35 , pp. 261-267
    • Flanagan, R.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.